• Western blot analysis of lysate from Jurkat cells, using Meis1 antibody.
  • Western blot analysis of K562 lysis using Meis1 antibody. Antibody was diluted at 1:1000 cells nucleus extracted by Minute TM Cytoplasmic and Nuclear Fractionation kit (SC-003, Inventbiotech, MN, USA).

Anti-MEIS1 antibody (229-278 aa) (STJ94071)

SKU:
STJ94071

Current Stock:
Host: Rabbit
Applications: WB/IHC
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Homeobox protein Meis1 (229-278 aa) is suitable for use in Western Blot and Immunohistochemistry research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
IHC-P 1:50-300
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: MEIS1
Gene ID: 4211
Uniprot ID: MEIS1_HUMAN
Immunogen Region: 229-278 aa
Specificity: Meis1 Polyclonal Antibody detects endogenous levels of Meis1 protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human Meis1 at the amino acid range 229-278
Function Acts as a transcriptional regulator of PAX6. Acts as a transcriptional activator of PF4 in complex with PBX1 or PBX2. Required for hematopoiesis, megakaryocyte lineage development and vascular patterning. May function as a cofactor for HOXA7 and HOXA9 in the induction of myeloid leukemias.
Protein Name Homeobox Protein Meis1
Database Links Reactome: R-HSA-5617472
Cellular Localisation Nucleus
Alternative Antibody Names Anti-Homeobox Protein Meis1 antibody
Anti-MEIS1 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance